<?xml version="1.0" encoding="UTF-8"?>
<p id="par0070">Assessment of the patient epidemiological history revealed that the patient, a 64-year-old female, returned to Guizhou from Wuhan, China, on January 12, 2020, and developed symptoms, including low fewer and cough, on February 11, 2020. On February 12, 2020, she was hospitalized after SARS-CoV-2 infection was confirmed at Jiangjunshan Hospital. The first post-admission chest computed tomography (CT) imaging showed that the patient had 1) lobular patchy hyperdense shadows in both lungs, 2) emphysema, 3) cardiomegaly, and 4) aortic sclerosis. A routine blood test revealed the following counts: total white blood cells, 7. 4 × 109/L; neutrophils, 77.2%; and lymphocytes, 13.4%. On February 19, 2020, the patient was transferred to the ICU due to deterioration in her condition. After treatment, her condition improved, and she tested negative twice for SARS-CoV-2 on March 8 and 9, 2020. She then continued to be isolated and under observation for an additional 14 days (
 <xref rid="fig0015" ref-type="fig">Fig. 3</xref> ).
</p>
